Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > U.S price up.....go figure

<< Previous

Bullboard Posts

Next >>

Comment by Moonshiner592on Jun 26, 2020 6:17pm

196 Views

Post# 31197429

RE:U.S price up.....go figure

HighSkies2019 wrote: Yes I see what you mean re price ..and can't help but notice no Penny/Edrose past week.. we were expecting update end of june re GVHD .... let's see if we get a NR with everything ...have a nice weekend ...glta

... could there be ties to the financials and "something" with GVHD? ... (just some before-the-weekend-food-for-thought)

<< Previous

Bullboard Posts

Next >>

Parliament looks for your word on potential Chinese-made EV tariffs